For instance, glioblastomas with an inactivating hypermethylation of the promoter of the MGMT gene (O6-methylguanine-DNA methyltransferase) exhibit defective DNA repair in response to alkylation and are therefore sensitive to alkylating chemotherapy agents such as temozolomide. This evidence concerns the gene MGMT and glioblastoma.